Patent Yard Sign in
Canadian application, no grantCanada

Fanconi-gene ii

CA 2285605 A1 · Owner: Kubbies, Manfred · Inventors: Machl, Andreas; Planitzer, Simone; Kubbies, Manfred

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention concerns a pathophysiologically relevant gene associated with Fanconi anaemia (FA) a, polypeptide coded thereby, an antibody directed against the polypeptide as well as the pharmaceutical applications of the nucleic acid, polypeptide and antibody.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 6, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 6, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 6, 1998
GrantedNo grant recorded
Term endedApril 6, 2018
Patent numberCA 2285605 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedApril 6, 1998Term endedApril 6, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.